Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-036764
Filing Date
2026-08-10
Accepted
2026-08-10 09:00:37
Documents
57
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1274778
2 EX-31.1 ex31-1.htm EX-31.1 18528
3 EX-31.2 ex31-2.htm EX-31.2 18188
4 EX-32.1 ex32-1.htm EX-32.1 8411
5 EX-32.2 ex32-2.htm EX-32.2 8739
  Complete submission text file 0001493152-26-036764.txt   6163750

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE maia-20260630.xsd EX-101.SCH 39231
7 XBRL CALCULATION FILE maia-20260630_cal.xml EX-101.CAL 40341
8 XBRL DEFINITION FILE maia-20260630_def.xml EX-101.DEF 163312
9 XBRL LABEL FILE maia-20260630_lab.xml EX-101.LAB 371061
10 XBRL PRESENTATION FILE maia-20260630_pre.xml EX-101.PRE 291403
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1005333
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 261256442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)